Keyhani-Rofagha S, Palma T, O'Toole R V
Department of Pathology, Ohio State University Medical Center, Columbus 43210, USA.
Diagn Cytopathol. 1996 Jun;14(4):316-20. doi: 10.1002/(SICI)1097-0339(199605)14:4<316::AID-DC7>3.0.CO;2-D.
To determine if the PAPNET screening system can be used for quality control to lower false-negative rates for Pap smears 638 manually screened, "negative" Pap smears were subjected retrospectively to the PAPNET screening system. Twenty-nine of the smears came from 18 patients who subsequently had biopsyproven high-grade squamous intraepithelial lesions (SIL). The remaining 609 negative smears were arbitrarily selected as controls. One hundred twenty-eight (128) of the retrospectively reviewed smears (20%) were selected by PAPNET for microscopic referral because of potential abnormalities. Abnormalities were confirmed on 14 of these smears upon microscopic evaluation. Five of these 14 smears were from smears obtained from four of the 18 women with high-grade SIL. The incidence of manually screened false-negatives detected by PAPNET rescreening was 14/638 or 2.2% for the entire patient population in this study and 5/29 or 17.24% for the targeted patients known to have subsequently developed highgrade lesions. The 2.2% decrease in the false-negative rate in this experiment may be partly artificial as this study group was seeded with false-negative cases at high risk for containing missed abnormalities. The implementation of the PAPNET system for quality control may lower false-negative rates for Pap smears.
为了确定PAPNET筛查系统是否可用于质量控制以降低巴氏涂片的假阴性率,对638份经人工筛查为“阴性”的巴氏涂片进行了回顾性的PAPNET筛查系统检测。其中29份涂片来自18名患者,这些患者随后经活检证实患有高级别鳞状上皮内病变(SIL)。其余609份阴性涂片被随机选为对照。在回顾性检测的涂片中,有128份(20%)因潜在异常被PAPNET系统选中进行显微镜检查。经显微镜评估,其中14份涂片被确认为异常。这14份涂片中的5份来自18名患有高级别SIL的女性中的4名患者的涂片。在本研究中,通过PAPNET重新筛查检测出的人工筛查假阴性率在整个患者群体中为14/638或2.2%,在已知随后发生高级别病变的目标患者中为5/29或17.24%。本实验中假阴性率2.2%的降低可能部分是人为因素,因为该研究组中植入了存在漏诊异常高风险的假阴性病例。实施PAPNET系统进行质量控制可能会降低巴氏涂片的假阴性率。